A REVOLUTIONARY APPROACH WITH A GAME-CHANGING TECHNOLOGY
All-ScaleFlow™-based-equipment allows to produce mRNA vaccines and therapeutics faster, all over the world, at any scale!
Doses
Minimum scale
Doses
Annual capacity
Only
Equipment footprint
PARTNERS
They trust us
NEWS
Flora Binder to join Dillico as Chief Development Officer
We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our [...]
French Tech Emergence Grant for Dillico
Dillico is pleased to announce that it has been awarded a French Tech Emergence grant by BPIFrance, which we thank. This financial support is granted to startup projects that develop a disruptive innovation [...]
Dillico to take advantage of Rhône-Alpes and Grenoble’s strong academic and high-technology industrial roots
Dillico is located in Grenoble, in the French Alps. It is not only a beautiful region, but also a place with a strong local environment to support future growth. GRENOBLE Highest density of [...]